Article Details

Biocytogen Enters into RenMab™/RenLite™ Licensing Agreement with Xencor

Retrieved on: 2020-12-07 15:45:00

Tags for this article:

Click the tags to see associated articles and topics

Biocytogen Enters into RenMab™/RenLite™ Licensing Agreement with Xencor. View article details on hiswai:

Excerpt

... Mouse platform to enhance Xencor's <b>monoclonal antibody</b> drug discovery research. The leading platform for fully human antibody generation.

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo